The effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients

scientific article published on 14 June 2018

The effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJPAM.2018.04.001
P932PMC publication ID6363253
P698PubMed publication ID30805535

P2093author name stringAbdelmoneim Eldali
Zuhair Al-Hassnan
Bedour Handoom
Dana Al-Qasabi
Eman Megdad
Moeenaldeen Dia Alsayed
Munirah Al Mesned
Reem Hawary
Samir Al-Nufiee
P2860cites workLiving with phenylketonuria: perspectives of patients and their familiesQ23910648
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesQ29614505
Effect of dietary regime on metabolic control in phenylketonuria: Is exact calculation of phenylalanine intake really necessary?Q33800143
Assessment of adult phenylketonuriaQ34391888
Inherited Metabolic Disorders: Aspects of Chronic Nutrition ManagementQ35889337
Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literatureQ36880362
Saudi newborn screening. A national public health program: needs, costs, and challenges.Q36901611
Barriers to drug adherence in the treatment of urea cycle disorders: Assessment of patient, caregiver and provider perspectivesQ37131504
Recommendations for the nutrition management of phenylalanine hydroxylase deficiencyQ37570443
The reality of dietary compliance in the management of phenylketonuriaQ37725745
Weaning infants with phenylketonuria: a reviewQ37912252
Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unitQ37912800
Vitamin B12 deficiency and phenylketonuriaQ37913687
Nutrition in phenylketonuriaQ37938086
High prevalence of overweight and obesity in females with phenylketonuriaQ38030669
Adherence issues in inherited metabolic disorders treated by low natural protein diets.Q38064765
The challenges of vitamin and mineral supplementation in children with inherited metabolic disorders: a prospective trial.Q38701869
Expanded Newborn Screening Program in Saudi Arabia: Incidence of screened disordersQ38880427
Metabolic Diet App Suite for inborn errors of amino acid metabolismQ38922675
Special low protein foods for phenylketonuria: availability in Europe and an examination of their nutritional profile.Q40181778
Micronutrient in hyperphenylalaninemiaQ40591285
Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuriaQ41669742
Non-compliance and professional powerQ41727051
Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuriaQ44519974
Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapyQ44578451
Body mass index in adult patients with diet-treated phenylketonuriaQ44729161
Application of the WHOQOL-100 for the assessment of quality of life of adult patients with inherited metabolic diseasesQ48471589
Psychological and social findings in adolescents with phenylketonuriaQ48833634
Dietary treatment of destructive behavior associated with hyperphenylalaninemia.Q51994678
Predicting health-related quality of life of parents of children with inherited metabolic diseases.Q53106648
Feeding difficulties in children with inherited metabolic disorders: a pilot study.Q53666978
The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine diseaseQ67353670
Zinc and copper status of treated children with phenylketonuriaQ70670463
Effects of a low selenium state in patients with phenylketonuriaQ73552217
Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed dietQ73641271
Adherence to long-term therapies: evidence for actionQ79358413
Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU)Q83120493
Adherence to diet and quality of life in patients with phenylketonuriaQ83461470
Physical development in patients with phenylketonuria on dietary treatment: a retrospective studyQ84857941
P433issue2
P304page(s)60-68
P577publication date2018-06-14
P1433published inInternational Journal of Pediatrics and Adolescent MedicineQ50817115
P1476titleThe effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients
P478volume5

Search more.